Experimental skin cream linked to 2-year drop in biological age in early study

An experimental skin cream altered molecular markers associated with aging and inflammation in an early human trial, according to preliminary data released by its developer this week.

Rubedo Life Sciences, a biotechnology company based in Mountain View, California, tested its investigational treatment, RLS-1496, in patients with eczema and other skin conditions.

In an analysis of 11 paired skin samples from patients with atopic dermatitis, researchers reported that four weeks of treatment...